UBS raised the firm’s price target on Johnson Matthey to 1,950 GBp from 1,650 GBp and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on JMPLY: Johnson Matthey signs definitive agreement to sell its MDC business to Montagu Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m